ARTICLE | Company News

ViroPharma sales and marketing update

December 19, 2011 8:00 AM UTC

ViroPharma launched Buccolam midazolam in the U.K. to treat prolonged, acute, convulsive seizures in patients three months to 17 years. Infants three to six months old receiving the oral formulation of midazolam for buccal delivery should be treated in a hospital setting. Details were not disclosed. ...